首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Enrichment of mutant alleles by chromatographic removal of wild type alleles: a new principle for the detection of alleles with unknown point mutations at excess of wild type alleles.
【24h】

Enrichment of mutant alleles by chromatographic removal of wild type alleles: a new principle for the detection of alleles with unknown point mutations at excess of wild type alleles.

机译:通过色谱去除野生型等位基因来富集突变体等位基因:检测野生型等位基因过量时具有未知点突变的等位基因的新原理。

获取原文
获取原文并翻译 | 示例
           

摘要

In human carcinomas, mutations that alter tumour genes such as the KRAS, P53, or APC genes, are mostly point mutations. The detection of mutant alleles of tumour genes in specimens such as urine, pancreatic juice, sputum, and stool holds great promise for an early diagnosis of cancer. In addition, the detection of mutant tumour genes in tissue samples, such as lymph nodes or resection margins, may allow a sensitive diagnosis of residual malignant disease. However, the reliable detection of mutant alleles in excess of wild type alleles remains an unresolved analytical problem when the mutations are not known a priori. In the present communication, a new approach is described which makes possible the detection of unknown point mutations in tumour genes at excess of wild type alleles. The method is based on the removal of wild type alleles by hybridisation to immobilised complementary oligonucleotides. Using this approach, an enrichment of mutant KRAS, P53 and APC alleles of one mutant in up to 10(3) normal alleles has been achieved. Parallel miniaturised separation units with oligonucleotides complementary to defined sequences of a wild type allele should allow the detection of unknown point mutations as well as small insertions or deletions which occur in the sequence range covered by the oligonucleotides.
机译:在人类癌症中,改变肿瘤基因(例如KRAS,P53或APC基因)的突变主要是点突变。在尿液,胰液,痰液和粪便等标本中检测到肿瘤基因的突变等位基因,有望对癌症进行早期诊断。另外,检测组织样品中的突变肿瘤基因,例如淋巴结或切除切缘,可以敏感地诊断残留的恶性疾病。然而,当先验未知突变时,可靠地检测超过野生型等位基因的突变等位基因仍然是一个未解决的分析问题。在本通讯中,描述了一种新的方法,该方法使检测野生型等位基因过量的肿瘤基因中的未知点突变成为可能。该方法基于通过与固定的互补寡核苷酸杂交除去野生型等位基因。使用这种方法,已经实现了一个突变体的突变KRAS,P53和APC等位基因在多达10(3)个正常等位基因中的富集。具有与野生型等位基因的确定序列互补的寡核苷酸的平行微型分离单元应允许检测未知点突变以及在寡核苷酸覆盖的序列范围内发生的小插入或缺失。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号